Background
- Fluoroquinolone antibiotic with antipseudomonal activity
- Inhibits CYP1A2
Clinical Breakpoints
- For the Enterobacteriaceae changed recently
- MIC of 1 previously reported as susceptible but had reports of reduced susceptibility in practice
- New cutoff is 0.5 for susceptibility
